Cargando…
Development of Neutralizing Antibodies against Zika Virus Based on Its Envelope Protein Structure
As we know more about Zika virus (ZIKV), as well as its linkage to birth defects (microcephaly) and autoimmune neurological syndromes, we realize the importance of developing an efficient vaccine against it. Zika virus disease has affected many countries and is becoming a major public health concern...
Autores principales: | Yang, Chunpeng, Gong, Rui, de Val, Natalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513807/ https://www.ncbi.nlm.nih.gov/pubmed/31020573 http://dx.doi.org/10.1007/s12250-019-00093-5 |
Ejemplares similares
-
Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice
por: Chen, Mei-Yu, et al.
Publicado: (2020) -
Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies
por: Gallichotte, Emily N., et al.
Publicado: (2019) -
Plant‐produced Zika virus envelope protein elicits neutralizing immune responses that correlate with protective immunity against Zika virus in mice
por: Yang, Ming, et al.
Publicado: (2017) -
A new class of broadly neutralizing antibodies that target the glycan loop of Zika virus envelope protein
por: Qu, Panke, et al.
Publicado: (2020) -
The effect of single mutations in Zika virus envelope on escape from broadly neutralizing antibodies
por: Kikawa, Caroline, et al.
Publicado: (2023)